Public health risks from subclinical variant CJD

Abigail B Diack¹, Robert G Will², Jean C Manson^{1

3

4}

Affiliations

¹ The Roslin Institute & R(D)SVS, University of Edinburgh, Easter Bush, United Kingdom.
² National CJD Research and Surveillance Unit, University of Edinburgh, Edinburgh, United Kingdom.
³ The Centre for Dementia Prevention, University of Edinburgh, Edinburgh, United Kingdom.
⁴ Edinburgh Neuroscience, University of Edinburgh, Edinburgh, United Kingdom.

Review

Abigail B Diack et al. PLoS Pathog. 2017.

. 2017 Nov 30;13(11):e1006642.

doi: 10.1371/journal.ppat.1006642. eCollection 2017 Nov.

Abigail B Diack¹, Robert G Will², Jean C Manson^{1

3

4}

¹ The Roslin Institute & R(D)SVS, University of Edinburgh, Easter Bush, United Kingdom.
² National CJD Research and Surveillance Unit, University of Edinburgh, Edinburgh, United Kingdom.
³ The Centre for Dementia Prevention, University of Edinburgh, Edinburgh, United Kingdom.
⁴ Edinburgh Neuroscience, University of Edinburgh, Edinburgh, United Kingdom.

No abstract available

Conflict of interest statement

The authors have declared that no competing interests exist.

1. National CJD Research and Surveillance Unit (2017) Creutzfeldt-Jakob disease in the UK. http://www.cjd.ed.ac.uk. Accessed on August 22, 2017.
1. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, et al. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5: 393–398. doi: 10.1016/S1474-4422(06)70413-6 - DOI - PubMed
1. Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, et al. (2014) Variant CJD. 18 years of research and surveillance. Prion 8: 286–295. doi: 10.4161/pri.29237 - DOI - PMC - PubMed
1. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–529. doi: 10.1016/S0140-6736(04)16811-6 - DOI - PubMed
1. Bishop MT, Diack AB, Ritchie DL, Ironside JW, Will RG, et al. (2013) Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 136: 1139–1145. - PMC - PubMed